Table 2. Regression model estimating associations between diagnostic interval and number of ‘competing demand’ and/or ‘alternative explanation’ conditions.
Coeff. (95% CI) | P-value | Exponentiated coeff. (95% CI) | Diagnostic interval change in days (95% CI)a | |
---|---|---|---|---|
Female gender | 0.02 (−0.05, 0.09) | 0.544 | 1.02 (0.95, 1.09) | 2 (−3, 7) |
Age group (years)b | 0.07 (0.05, 0.09) | <0.001 | ||
40–59 (reference) | 0.00 | — | 1.00 | |
60–64 | −0.13 (−0.27, 0.02) | 0.083 | 0.88 (0.76, 1.02) | −9 (−18, 1) |
65–69 | 0.05 (−0.09, 0.18) | 0.505 | 1.05 (0.91, 1.20) | 4 (−7, 15) |
70–74 | 0.06 (−0.08, 0.19) | 0.395 | 1.06 (0.93, 1.21) | 5 (−6, 16) |
75–79 | 0.10 (−0.03, 0.23) | 0.132 | 1.11 (0.97, 1.26) | 8 (−2, 20) |
80–84 | 0.32 (0.19, 0.45) | <0.001 | 1.38 (1.21, 1.57) | 29 (16, 44) |
85+ | 0.34 (0.21, 0.48) | <0.001 | 1.41 (1.23, 1.62) | 31 (17, 47) |
No. of 'competing demand' conditionsb | 0.09 (0.06, 0.12) | <0.001 | ||
None (reference) | 0.00 | — | 1.00 | |
One | 0.12 (0.03, 0.21) | 0.009 | 1.13 (1.03, 1.24) | 10 (2, 18) |
Two | 0.20 (0.10, 0.30) | <0.001 | 1.22 (1.11, 1.34) | 17 (8, 26) |
Three | 0.30 (0.18, 0.41) | <0.001 | 1.34 (1.20, 1.51) | 26 (15, 39) |
Four or more | 0.35 (0.20, 0.49) | <0.001 | 1.41 (1.22, 1.63) | 32 (17, 49) |
No. of 'alternative explanation' conditionsb | 0.09 (0.03, 0.14) | 0.003 | ||
None (reference) | 0.00 | — | 1.00 | |
One | 0.12 (0.04, 0.19) | 0.003 | 1.12 (1.04, 1.21) | 9 (3, 16) |
Two or more | 0.13 (−0.01, 0.27) | 0.061 | 1.14 (0.99, 1.32) | 11 (0, 24) |
Inflammatory bowel disease | 0.29 (0.17, 0.41) | <0.001 | 1.34 (1.18, 1.51) | 26 (14, 39) |
Non-colorectal cancer | 0.11 (−0.05, 0.28) | 0.173 | 1.12 (0.95, 1.32) | 9 (−4, 24) |
Abbreviation: CI=confidence interval.
Calculated using the geometric mean (as used by the log-tranformed regression model) of 76.71.
Sensitivity analyses entered these covariates as ordinal variables to assess their global effects, which are reported above the effects of their separate levels.